BioButton Device for Walking Problems

Overseen By Carly Riedmann, MPH

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Charles Lin

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

70 Participants Needed

Trial Summary

What is the purpose of this trial?

This pilot study will explore the use of the BioIntellisense BioButton, a remote wearable multi-parameter monitor, to identify gait disturbances that occur as a side effect of polypharmacy.

Research Team

Charles Lin, MD

Principal Investigator

UPMC, University of Pittsburgh

Eligibility Criteria

This trial is for adults over 18 who have documented gait issues in their medical records. It's not suitable for non-English speakers, those unable to consent due to cognitive problems, or individuals who are bedbound or can't stand.

Inclusion Criteria

I am older than 18 years.

My walking ability is documented in my medical records.

Exclusion Criteria

I am bedbound and cannot stand up.

Non-English-speaking patients

I am under 18 years old.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants wear the BioButton device continuously for 30 days to collect physiologic and gait data

4 weeks

Continuous monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• BioButton

Trial Overview The study tests the BioIntellisense BioButton, a wearable device that monitors various health parameters to detect gait disturbances caused by taking multiple medications.

Participant Groups

Group I: Patient Group Experimental Treatment 1 Intervention

Patients in this arm will wear the device, BioButton, continuous for 30 days as it collects physiologic and gait data, while receiving otherwise routine, standard of care.

Group II: Nurse Group Experimental Treatment 1 Intervention

Nurses caring for patients wearing the device, BioButton, will assist in placing and removing the device. Otherwise, they will provide routine, standard of care to the enrolled patients to determine the overall feasibility of the device for clinical care providers.

Who Is Running the Clinical Trial?

Charles Lin

Lead Sponsor

Trials

1

Recruited

70+

Jewish Healthcare Foundation

Collaborator

Trials

1

Recruited

70+